BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260603T160000
DTEND;TZID=Europe/Stockholm:20260603T170000
DTSTAMP:20260917T040058
CREATED:20260520T073159Z
LAST-MODIFIED:20260520T104309Z
UID:37020-1780502400-1780506000@senzagen.com
SUMMARY:Webinar: In vitro skin sensitization potency assessment - Part 2
DESCRIPTION:Difficult-to-test samples: Natural Complex Substances and Cosmetic Formulations\nJoin us for the second webinar in our series\, further exploring the challenges and opportunities of New Approach Methodologies (NAMs) for in vitro skin sensitization potency testing\, with a special focus on difficult-to-test substances. \nIn this session\, Dr Julie Anne Cote from The Honest Company\, Dr Isabelle Lee from the Research Institute for Fragrance Materials (RIFM)\, and Dr Andy Forreryd from SenzaGen will present new GARD® data and case studies on Natural Complex Substances and Cosmetic Formulations. \nYou will gain insight into how GARD® skin Dose-Response\, a single-assay method based on genomics and machine-learning technology\, performs on natural complex mixtures and supports critical decision-making during product development. Specifically\, you will learn how it can: \n\nDetect low levels of sensitizers in complex cosmetic formulations.\nDefine safe dose levels.\nGuide formulation optimization decisions.\n\nWith broad applicability to complex mixtures and novel raw materials with challenging properties\, GARD® provides a powerful non-animal solution for assessing skin sensitization potency. \n  \n \nKey topics\n\nIntroduction to the genomics and machine-learning based GARD® technology for in vitro skin sensitization potency assessment.\nPerformance evaluation of the GARD® skin Dose-Response assay for natural complex fragrance ingredients.\nCase studies on Natural Complex Substances and Cosmetic Formulations.\n\nThe webinar will last around 45 minutes\, followed by a live Q&A. If you cannot attend the live event\, make sure to register to get access to the recording. \nSpeakers\n  \n \nAndy Forreryd\, PhD\nScientific Liaison Manager @ SenzaGen \n\nCo-developer of the GARD®skin assay (OECD TG 442E).\nMember of the ISO/TC 194/WG 8 on irritation and sensitization.\nMember of OECD expert group on respiratory sensitization.\n\n\nGARD® for in vitro skin sensitization potency assessment \n\n  \n \nIsabelle Lee\, PhD\nManager of Human Health Science & Strategy @ RIFM \n\nLeads human health science and strategy\, advancing NAMs for ingredient safety.\nHead of skin sensitization team\, overseeing safety assessments and research programs.\nExpert in consumer product ingredient evaluation with a PhD in Pharmacology (UPenn).\n\nAnalysis of natural complex fragrance ingredients in the GARDskin Dose-Response assay \n  \n \nJulie Anne Cote\, PhD\nSr. Clinical & Safety Compliance Research Scientist @ The Honest Company \n\nLeads safety\, clinical testing\, and product claim substantiation across multiple product categories.\nExpert in personal care and consumer goods safety compliance\, including baby care\, beauty\, and feminine hygiene.\nCombines scientific expertise and compliance leadership to effectively translate complex data into transparent\, science-backed consumer messaging.\n\nSkin sensitization potency assessment of complex cosmetic formulations \n 
URL:https://senzagen.com/event/2026-webinar-in-vitro-skin-sensitization-potency-assessment-part-2/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2025/01/Lime-UNIVERSAL-webinar.jpg
END:VEVENT
END:VCALENDAR